Vivos (RDGL) Return on Sales Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vivos | - | - | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14.00 |
| Sep 30, 2025 | -251.00 |
| Dec 31, 2024 | 131.00 |
| Sep 30, 2024 | -81.00 |
| Mar 31, 2023 | 10.00 |
| Dec 31, 2022 | 1,475.00 |
| Sep 30, 2022 | 822.00 |
| Jun 30, 2022 | 147.00 |
| Mar 31, 2022 | 49.00 |
| Dec 31, 2021 | 695.00 |
| Sep 30, 2021 | 25.00 |
| Dec 31, 2020 | -317.00 |
| Sep 30, 2020 | 191.00 |
| Dec 31, 2019 | 415.00 |
| Sep 30, 2019 | 100.00 |
| Mar 31, 2018 | -27.00 |
| Dec 31, 2017 | -1,524.00 |
| Sep 30, 2017 | -828.00 |
| Jun 30, 2017 | -174.00 |
| Mar 31, 2017 | -86.00 |
| Dec 31, 2016 | -794.00 |
| Sep 30, 2016 | -28.00 |
| Jun 30, 2016 | -1,017.00 |
| Mar 31, 2016 | -1,420.00 |
| Dec 31, 2015 | 261.00 |